What happened to 444 startups once valued at $1B+.
| OUTCOME | COMPANIES | SHARE | COMBINED PEAK | MEDIAN DECLINE (n) |
|---|---|---|---|---|
| ๐ Dead / Bankrupt | 129 | 29% | $443.3B | โ100% (n=129) |
| ๐ Public < $1B | 138 | 31% | $574.5B | โ93% (n=138) |
| ๐ค Acquired | 76 | 17% | $243.4B | โ90% (n=75) |
| โ๏ธ Markdown | 101 | 23% | $370.9B | โ81% (n=86) |
| All former unicorns | 444 | 100% | $1.63T | โ$1.47T vaporized |
| COMPANY | PEAK | FELL | OUTCOME |
|---|---|---|---|
| WeWork | $47B โ19 | 2023 | โ๏ธ |
| Juul Labs | $38B โ18 | ~2022 | โ๏ธ |
| FTX | $32B โ22 | 2022 | ๐ |
| Nikola* | $30B โ20 | 2025 | ๐ |
| LeEco / LeTV* | $25B โ15 | 2017 | ๐ |
| Farfetch* | $23B โ21 | 2022 | ๐ค |
| Byju's | $22B โ22 | ~2023 | ๐ |
Scope. All 444 entries in the Unitard Index on 23 Oct 2026: venture-backed companies once valued at $1B+ that a subsequent reported event put below $1B.
Total Vaporized. Calculated as aggregate peak valuation ($1.63T) minus latest reported outcome value, market cap, acquisition price, or complete equity write-off ($1,467.8B / โ$1.47T).
Declines. Median of the "from peak" figure shown on company pages, where published (sample size n shown). Dead / Bankrupt equity is recorded as โ100%.
Raised per day. Total capital raised รท estimated days from founding to recorded bankruptcy, restructuring or shutdown. Aggregate = total raised รท total days across companies. It is not operating cash burn, money spent, or investor losses.
Markdowns & Investors. Form NPORT-P marks reflect single institutional holders under ASC 820 fair-value rules, not whole-company valuations. Disclosed investor lists reflect historical Crunchbase round records, not current ownership or losses.
Sources & Independence. SEC filings, bankruptcy dockets, and verified financial press cited per company page. Full methodology: unitard.io/methodology. Raw CSV & charts: unitard.io/press, licensed CC BY 4.0 (investor columns excluded). Published by Common Parlance, Inc.; the company and its principals hold no short positions in any listed security.